UM cancer treatment reaches human clinical trials | News | montanakaimin.com
Researchers at the University of Montana's Center for Translational Medicine developed a cancer treatment now in human trials, leveraging a partnership with Inimmune. The compound, initially an influenza vaccine, was repurposed to boost the immune system's natural anti-cancer response. This collaboration, supported by $33 million in grants, integrates UM's academic ideas with Inimmune's business expertise, fostering innovation and potentially new cancer treatments.
Reference News
Researchers at the University of Montana's Center for Translational Medicine developed a cancer treatment now in human trials, leveraging a partnership with Inimmune. The compound, initially an influenza vaccine, was repurposed to boost the immune system's natural anti-cancer response. This collaboration, supported by $33 million in grants, integrates UM's academic ideas with Inimmune's business expertise, fostering innovation and potentially new cancer treatments.